Literature DB >> 7537715

Distribution of extracellular matrix components and their receptors in human lymphoid tissue and B-cell non-Hodgkin lymphomas.

L H Jaspars1, E Bloemena, P Bonnet, P Van der Valk, C J Meijer.   

Abstract

In this study the distribution patterns of various extracellular matrix components and their receptors (i.e. beta 1 integrins) in B-cell non-Hodgkin lymphomas were examined and compared to those in reactive lymphoid tissue. Neoplastic follicles within follicular lymphomas showed similar patterns to that observed in reactive follicles, which appeared to be strongly associated with the presence of follicular dendritic cells. Diffuse lymphomas of low and intermediate malignancy grade revealed features comparable to those of interfollicular areas of reactive lymphoid tissue, irrespective to which compartment the tumour cells were related. Highly malignant lymphomas, however, displayed unique extracellular matrix configurations, resulting from active matrix degradation by macrophages; this may support rapid tumour growth. Extranodal lymphomas showed virtually the same matrix patterns as their nodal counterparts, suggesting that (malignant) lymphoid cells generate (at least partly) their own specific microenvironment. In reactive lymphoid tissue beta 1 integrins were mainly found on resident cells and except for alpha 4, alpha 5 (and beta 1) the lymphoid cells expressed very little, if any, beta 1 integrins. In comparison, expression of these integrins on lymphoma cells was reduced (follicular lymphomas) or could not be detected at all (diffusely growing lymphomas); this might contribute to the growth pattern and metastatic properties of the tumours.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537715     DOI: 10.1111/j.1365-2559.1995.tb00640.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  4 in total

1.  Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome.

Authors:  Rosaura Esteve-Puig; Fina Climent; David Piñeyro; Eva Domingo-Domènech; Veronica Davalos; Maite Encuentra; Anna Rea; Nadia Espejo-Herrera; Marta Soler; Miguel Lopez; Vanessa Ortiz-Barahona; Gustavo Tapia; José-Tomás Navarro; Joan Cid; Lourdes Farré; Alberto Villanueva; Isolda Casanova; Ramon Mangues; Pablo Santamarina-Ojeda; Agustín F Fernández; Mario F Fraga; Miguel Angel Piris; Nitzan Kol; Chen Avrahami; Sharon Moshitch-Moshkovitz; Gideon Rechavi; Anna Sureda; Manel Esteller
Journal:  Blood       Date:  2021-02-18       Impact factor: 22.113

Review 2.  Infection of dendritic cells by lymphocytic choriomeningitis virus.

Authors:  N Sevilla; S Kunz; D McGavern; M B A Oldstone
Journal:  Curr Top Microbiol Immunol       Date:  2003       Impact factor: 4.291

3.  Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy.

Authors:  Giuseppe Gritti; Andrea Gianatti; Fiorella Petronzelli; Rita De Santis; Chiara Pavoni; Riccardo Lorenzo Rossi; Laura Cattaneo; Luigi Giusto Spagnoli; Silvia Ferrari; Andrea Rossi; Anna Maria Barbui; Alessandro Rambaldi
Journal:  Oncotarget       Date:  2018-01-03

4.  Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan.

Authors:  S Kunz; N Sevilla; D B McGavern; K P Campbell; M B Oldstone
Journal:  J Cell Biol       Date:  2001-10-15       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.